Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-009272
Filing Date
2026-01-09
Accepted
2026-01-09 19:34:21
Documents
1
Period of Report
2026-01-07

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8037
  Complete submission text file 0001193125-26-009272.txt   9549
Mailing Address C/O BIOAGE LABS, INC. 5885 HOLLIS STREET, SUITE 370 EMERYVILLE CA 94608
Business Address
Davidson Michael H. (Reporting) CIK: 0001573785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41562 | Film No.: 26524394

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)